Atopic Dermatitis

Allergy and Allergic Diseases, Second Edition

Volumn 2, Issue , 2009, Pages 1811-1830

  Proelss, Julia D ^a   Bieber, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Atopic dermatitis (AD) common chronic inflammatory skin disease; Atopy; Clinical features and course; Complications; Diagnostic criteria; Differential diagnosis; Histology; Pathogenesis; Prevalence; Trigger factors

Indexed keywords

EID: 84889437127     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300918.ch88     Document Type: Chapter

References (104)

1. Ahmad-Nejad, P., Mrabet-Dahbi, S., Breuer, K. et al. (2004) The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 113, 565-7.
2. Akdis, C. A., Akdis, M., Bieber, T. et al. (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 61, 969-87.
3. Alomar, A., Berth-Jones, J., Bos, J.D. et al. (2004) The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151 (suppl. 70), 3-27.
4. Aly, R., Maibach, H.I. & Shinefield, H.R. (1977) Microbial flora of atopic dermatitis. Arch Dermatol 113, 780-2.
5. Anon. (1993) Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 186, 23-31.
6. Asher, M.I., Montefort, S., Bjorksten, B. et al. (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368, 733-43.
7. Baud, O., Goulet, O., Canioni, D. et al. (2001) Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 344, 1758-62.
8. Bibel, D.J., Greenberg, J.H. & Cook, J.L. (1977) Staphylococcus aureus and the microbial ecology of atopic dermatitis. Can J Microbiol 23, 1062-8.
9. Bieber, T., De la Salle, H., Wollenberg, A. et al. (1992) Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 175, 1285-90.
10. Bode, H.H. (1980) Dwarfism following long-term topical corticosteroid therapy. JAMA 244, 813-14.
11. Bradley, M., Soderhall, C., Luthman, H., Wahlgren, C.F., Kockum, I. & Nordenskjold, M. (2002) Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 11, 1539-48.
12. Breuer, K., Werfel, T. & Kapp, A. (2005) Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol 6, 65-77.
13. Bussmann, C., Bockenhoff, A., Henke, H., Werfel, T. & Novak, N. (2006) Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 118, 1292-8.
14. Cardona, I.D., Cho, S.H. & Leung, D.Y. (2006) Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol 7, 273-9.
15. Cassano, N., Loconsole, F., Coviello, C. & Vena, G.A. (2006) Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol Pharmacol 19, 237-40.
16. Chan, J.L., Davis-Reed, L. & Kimball, A.B. (2004) Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 3, 315-18.
17. Cookson, W.O. (2001) The genetics of atopic dermatitis: strategies, candidate genes, and genome screens. J Am Acad Dermatol 45, S7-S9.
18. Cookson, W.O., Ubhi, B., Lawrence, R. et al. (2001) Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27, 372-3.
19. Darsow, U., Vieluf, D. & Ring, J. (1995) Atopy patch test with different vehicles and allergen concentrations: an approach to standardization. J Allergy Clin Immunol 95, 677-84.
20. Darsow, U., Vieluf, D. & Ring, J. (1999) Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol 40, 187-93.
21. Dawe, R.S. (2003) Ultraviolet A1 phototherapy. Br J Dermatol 148, 626-37.
22. Forrest, S., Dunn, K., Elliott, K. et al. (1999) Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 104, 1066-70.
23. Gordon, D.J., Ostlere, L.S. & Holden, C.A. (1997) Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls. Br J Dermatol 137, 921-7.
24. Grewe, M., Bruijnzeel-Koomen, C.A., Schopf, E. et al. (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19, 359-61.
25. Griffiths, C.E., Katsambas, A., Dijkmans, B.A. et al. (2006) Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol 155 (suppl. 2), 1-16.
26. Hamid, Q., Boguniewicz, M. & Leung, D.Y. (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94, 870-6.
27. Hanifin, J. & Rajka, G. (1980) Diagnostic features of atopic eczema. Acta Derm Venereol 92, 44-7.
28. Hassan, A.S., Kaelin, U., Braathen, L.R. & Yawalkar, N. (2007) Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab. J Am Acad Dermatol 56(2), 217-21.
29. Hershey, G.K., Friedrich, M.F., Esswein, L.A., Thomas, M.L. & Chatila, T.A. (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337, 1720-5.
30. Hijnen, D.J., Ten Berge, O., Timmer-De Mik, L., Bruijnzeel-Koomen, C.A. & de Bruin-Weller, M.S. (2007) Efficacy and safety of longterm treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol 21, 85-9.
31. Homey, B., Steinhoff, M., Ruzicka, T. & Leung, D.Y. (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118, 178-89.
32. Hon, K.L., Leung, T.F., Kam, W.Y., Lam, M.C., Fok, T.F. & Ng, P.C. (2006) Dietary restriction and supplementation in children with atopic eczema. Clin Exp Dermatol 31, 187-91.
33. Hosoi, J., Murphy, G.F., Egan, C.L. et al. (1993) Regulation of Langerhans cell function by nerves containing calcitonin generelated peptide. Nature 363, 159-63.
34. Howell, M.D., Gallo, R.L., Boguniewicz, M. et al. (2006) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24, 341-8.
35. Iskedjian, M., Piwko, C., Shear, N.H., Langley, R.G. & Einarson, T.R. (2004) Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. Am J Clin Dermatol 5, 267-79.
36. Jacobi, A., Antoni, C., Manger, B., Schuler, G. & Hertl, M. (2005) Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 52, 522-6.
37. Johansson, S.G., Bieber, T., Dahl, R. et al. (2004) Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113, 832-6.
38. Juenger, M., Ladwig, A., Staecker, S. et al. (2006) Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin 22, 739-50.
39. Kerschenlohr, K., Decard, S., Przybilla, B. & Wollenberg, A. (2003) Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 111, 869-74.
40. Krathen, R.A. & Hsu, S. (2005) Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 53, 338-40.
41. Lane, J.E., Cheyney, J.M., Lane, T.N., Kent, D.E. & Cohen, D.J. (2006) Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol 54, 68-72.
42. Lee, Y.A., Wahn, U., Kehrt, R. et al. (2000) A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 26, 470-3.
43. Leung, D.Y., Harbeck, R., Bina, P. et al. (1993) Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92, 1374-80.
44. Liu, Y.J. (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203(2), 269-73.
45. McGirt, L.Y. & Beck, L.A. (2006) Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 118, 202-8.
46. Mastrandrea, F., Serio, G., Minelli, M. et al. (2000) Specific sublingual immunotherapy in atopic dermatiti. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr) 28, 54-62.
47. Matricardi, P.M. & Ronchetti, R. (2001) Are infections protecting from atopy? Curr Opin Allergy Clin Immunol 1, 413-19.
48. Meggitt, S.J. & Reynolds, N.J. (2001) Azathioprine for atopic dermatitis. Clin Exp Dermatol 26, 369-75.
49. Meggitt, S.J., Gray, J.C. & Reynolds, N.J. (2006) Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 367, 839-46.
50. Mittermann, I., Aichberger, K.J., Bunder, R., Mothes, N., Renz, H. & Valenta, R. (2004) Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol 4, 367-71.
51. Morar, N., Bowcock, A.M., Harper, J.I., Cookson, W.O. & Moffatt, M.F. (2006) Investigation of the chromosome 17q25 PSORS2 locus in atopic dermatitis. J Invest Dermatol 126(3), 603-6.
52. Morren, M.A., Przybilla, B., Bamelis, M., Heykants, B., Reynaers, A. & Degreef, H. (1994) Atopic dermatitis: triggering factors. J Am Acad Dermatol 31, 467-73.
53. Mothes, N., Niggemann, B., Jenneck, C. et al. (2005) The cradle of IgE autoreactivity in atopic eczema lies in early infancy. J Allergy Clin Immunol 116, 706-9.
54. Murray, M.L. & Cohen, J.B. (2007) Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 32, 23-7.
55. Neis, M.M., Peters, B., Dreuw, A. et al. (2006) Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 118, 930-7.
56. Nomura, I., Goleva, E., Howell, M.D. et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171, 3262-9.
57. Nomura, T., Sandilands, A., Akiyama, M. et al. (2007) Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119, 434-40.
58. Novak, N. & Bieber, T. (2003) Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112, 252-62.
59. Novak, N. & Bieber, T. (2005) The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 53, S171-S176.
60. Novak, N., Valenta, R., Bohle, B. et al. (2004a) FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113, 949-57.
61. Novak, N., Allam, J.P., Hagemann, T. et al. (2004b) Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 114, 364-70.
62. Novak, N., Kruse, S., Potreck, J. et al. (2005) Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 115, 828-33.
63. Ochs, H.D., Ziegler, S.F. & Torgerson, T.R. (2005) FOXP3 acts as a rheostat of the immune response. Immunol Rev 203, 156-64.
64. Ong, P.Y., Ohtake, T., Brandt, C. et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347, 1151-60.
65. Ou, L.S., Goleva, E., Hall, C. & Leung, D.Y. (2004) T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 113, 756-63.
66. Pajno, G.B., Peroni, D.G., Barberio, G. & Boner, A.L. (2003) Efficacy of sublingual immunotherapy in asthma and eczema. Chem Immunol Allergy 82, 77-88.
67. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A. et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38, 441-6.
68. Proksch, E., Folster-Holst, R. & Jensen, J.M. (2006) Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 43, 159-69.
69. Przybilla, B., Ring, J., Enders, F. & Winkelmann, H. (1991) Stigmata of atopic constitution in patients with atopic eczema or atopic respiratory disease. Acta Derm Venereol 71, 407-10.
70. Raap, U. & Kapp, A. (2005) Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 5, 419-24.
71. Rieg, S., Steffen, H., Seeber, S. et al. (2005) Deficiency of dermcidinderived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174, 8003-10.
72. Ring, J., Bieber, T., Vieluf, D., Kunz, B. & Przybilla, B. (1991) Atopic eczema, Langerhans cells and allergy. Int Arch Allergy Appl Immunol 94, 194-201.
73. Rippke, F., Schreiner, V., Doering, T. & Maibach, H.I. (2004) Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 5, 217-23.
74. Sator, P.G., Schmidt, J.B. & Honigsmann, H. (2003) Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 48, 352-8.
75. Schmid-Grendelmeier, P., Fluckiger, S., Disch, R. et al. (2005) IgEmediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 115, 1068-75.
76. Schultz Larsen, F.V. & Holm, N.V. (1985) Atopic dermatitis in a population based twin series. Concordance rates and heritability estimation. Acta Derm Venereol Suppl 114, 159.
77. Shortman, K. & Naik, S.H. (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7, 19-30.
78. Silva, S.H., Guedes, A.C., Gontijo, B. et al. (2006) Influence of narrowband UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J Eur Acad Dermatol Venereol 20, 1114-20.
79. Simon, D., Braathen, L.R. & Simon, H.U. (2004) Eosinophils and atopic dermatitis. Allergy 59, 561-70.
80. Sonkoly, E., Muller, A., Lauerma, A.I. et al. (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117, 411-17.
81. Soumelis, V., Reche, P.A., Kanzler, H. et al. (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3, 673-80.
82. Spergel, J.M., Mizoguchi, E., Oettgen, H., Bhan, A.K. & Geha, R.S. (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103, 1103-11.
83. Staab, D., Diepgen, T.L., Fartasch, M. et al. (2006) Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 332, 933-8.
84. Stalder, J.F., Fleury, M., Sourisse, M., Rostin, M., Pheline, F. & Litoux, P. (1994) Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 131, 536-40.
85. Strachan, D.P. (1989) Hay fever, hygiene, and household size. BMJ 299, 1259-60.
86. Strickland, I., Hauk, P.J., Trumble, A.E., Picker, L.J. & Leung, D.Y. (1999) Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 112, 249-53.
87. Sugiura, K., Muro, Y., Nishizawa, Y. et al. (2007) LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J Invest Dermatol 127, 75-80.
88. Takiguchi, R., Tofte, S., Simpson, B. et al. (2007) Efalizumab for severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol 56, 222-7.
89. Tengvall Linder, M., Johansson, C., Bengtsson, A., Holm, L., Harfast, B. & Scheynius, A. (1998) Pityrosporum orbiculare-reactive T-cell lines in atopic dermatitis patients and healthy individuals. Scand J Immunol 47, 152-8.
90. Toda, M., Leung, D.Y., Molet, S. et al. (2003) Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111, 875-81.
91. Toyoda, M., Nakamura, M., Makino, T., Hino, T., Kagoura, M. & Morohashi, M. (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147, 71-9.
92. Valenta, R., Natter, S., Seiberler, S. et al. (1998) Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 111, 1178-83.
93. Verhagen, J., Akdis, M., Traidl-Hoffmann, C. et al. (2006) Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117, 176-83.
94. Wahlgren, C.F., Hagermark, O. & Bergstrom, R. (1990) The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 122, 545-51.
95. Weidinger, S., Illig, T., Baurecht, H. et al. (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118, 214-19.
96. Werfel, T., Breuer, K., Rueff, F. et al. (2006) Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61, 202-5.
97. Williams, H.C. (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352, 2314-24.
98. Williams, H. & Flohr, C. (2006) How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 118, 209-13.
99. Williams, H.C., Burney, P.G., Hay, R.J. et al. (1994) The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131, 383-96.
100. Wollenberg, A., Wen, S.P. & Bieber, T. (1995) Langerhans cell phenotyping: a new tool for differential-diagnosis of inflammatory diseases. Lancet 346, 1626-7.
101. Wollenberg, A., Kraft, S., Hanau, D. & Bieber, T. (1996) Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 106, 446-53.
102. Wollenberg, A., Wagner, M., Gunther, S. et al. (2002) Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 119, 1096-102.
103. Ziegler, S.F. (2006) FOXP3: of mice and men. Annu Rev Immunol 24, 209-26.
104. Zutavern, A., Hirsch, T., Leupold, W., Weiland, S., Keil, U. & Von Mutius, E. (2005) Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 35, 1301-8.